NCT04732663View on ClinicalTrials.gov

Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

March 4, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

May 6, 2024

Conditions
Covid19Dyspnea
Interventions
OTHER

No Intervention

Cross-sectional study, no intervention.

Trial Locations (1)

T6G2R3

Clinical Physiology Laboratory, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT04732663 - Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19 | Biotech Hunter | Biotech Hunter